Trial Profile
The otherness of intravitreal conbercept injection for exudative senile macular degeneration'patients of intraocular lens eye and phakic eye
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs Conbercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 28 Oct 2016 New trial record